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Actinomycosis is a chronic, suppurative, and granulomatous disease caused by an
anaerobic Gram-positive bacterium, Actinomyces israelii, manifesting itself as
fistula, sinus, inflammatory pseudotumor, or abscess formation.
1 Humans are
natural reservoirs and there is no documented person-to-person transmission of
the disease, and it is commonly cultured from carious teeth, tonsilar crypts.
2 It is
characterized by a tendency to feign malignancy due to its capacity to invade
surrounding tissues and to form masses.
3 Therefore, there are multiple clinical
presentations, often leading to misdiagnosis. The three main clinical forms of this
disease are cervicofacial, thoracic, and abdominopelvic. The cervicofacial region
accounts for 50% to 65%, followed by abdomen (20%).
4-6
The disease usually shows an indolent course with clinical symtoms and signs
that are not specific, resulting in delayed diagnosis. Actinomyces are sensitive to
penicillin, but the duration of treatment varies from several weeks to months to
achieve permanent recovery.
7-10 The aim of this study was to evaluate the charac-
teristic clinical features with short literature review on the topic.
Between January 2000 and January 2006, 22 patients with abdominopelvic
actinomycosis were identified. Patient’s demographic data and outcome are
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INTRODUCTION
MATERIALS AND METHODSsummarized in Table 1. The clinical data including age,
gender, mass size, preoperative diagnosis, presence and
duration of intrauterine device (IUD) were retrospectively
analyzed. Intrabdominal mass assessments consisted of
physical examination, colonoscopy, ultrasonography, and
abdominopelvic CT scan.
The clinical details of these patients are presented in Table
2. There were two men and twenty women with a mean
age of 42.8 (range, 24 - 69) years. Twelve patients
presented with masses or abdominal pain, whereas three
patients presented with acute appendicitis (Table 3).
Among the twenty two patients, only two patients presented
with a colonic mass mimicking colon cancer. Fifteen
patients (68.2%) had leukocytosis with a mean WBC
count of 12,765 mm
3 (range; 4,180 - 22,900 mm
3). None of
the patients presented with small bowel or colon obstruc-
tion. However, emergency surgery rate was 50% due to
peritonitis symptoms. A preoperative abdominal CT scan
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RESULTS
Table 1.Summary of 22 Patients with Intrabominal Actinomycosis
Patient Signs and 
Time 
Presence
Initial
Risk 
no.
Sex
symtom
to 
of IUD 
leukocyte Antibiotics
factors
Recurrences
diagnosis count (mm3)
1 F Painful mass 15 No 8,690 IV penicillin None None
2 F Abdominal pain 7 No 9,340 IV penicillin None None
3 F Abdominal pain 6 No 11,890 IV penicillin None None
4 F Abdominal pain 18 Yes 16,500 IV penicillin None None
5 F Fever 4 No 18,330 IV penicillin None None
6 F Abdominal pain 15 No 11,750 IV penicillin None None
7 F Abdominal pain 8 Yes 22,900 IV penicillin None None
8 F No symptom 3 Yes 13,570 IV penicillin None None
9 F Abdominal pain 7 No 5,950 IV penicillin None None
10 F Painful mass 14 No 9,440 IV penicillin None None
11 F Abdominal pain 15 No 8,990 IV penicillin Liver cirrhosis None
12 F Abdominal pain 17 No 15,300 IV doxycline None None
13 F Abdominal pain 7 Yes 20,940 IV ciprofloxacin None None
14 F Fever 12 Yes 7,400 IV penicillin None None
15 F Abdominal pain 9 No 14,560 IV penicillin None None
16 F Abdominal pain 19 No 16,210 IV penicillin None None
17 F Abdominal pain 17 Yes 7,650 IV penicillin None None
18 M Abdominal pain 13 N / A 4,180 IV penicillin DM None
19 M Abdominal pain 10 N / A 20,490 IV penicillin None None
20 F Abdominal pain 8 No 5,310 IV penicillin None None
21 F Painless mass 4 Yes 16,970 IV penicillin DM / Hypertension None
22 F Abdominal pain 6 Yes 14,480 IV penicillin None None
IUD, intrauterine device.
Table 2. Patients’ Characteristics
Intrabdominal actinomycosis
(n = 22)
Age (yrs)
Mean (range) 42.8 (24 - 69)
Gender: M / F 2 : 20
IUD (n = 20)
Yes 12 (60%)
No 8 (40%)
Emergency vs. elective operation
Yes 11 (50%)
No 11 (50%)
WBC, mm3
Mean (range) 12,765 (4,180 - 22,900)
GI obstruction
Yes 0 (0.0%)
No 100 (0.0%)
Mass size, cm
Mean (range) 5.5 (2.5 - 11.0)
IUD, intrauterine device; WBC, white blood cell; GI, gastrointestinal.or ultrasonography was done in all patients and detected
intrabdominal mass or abscess but failed to give a definite
diagnosis. The median operative time was 140 (range, 90 -
420) minutes and the median blood loss was 250 (range,
150 - 800) mL. The mean size of tumor was 5.5 (range, 2.5
- 11.0) cm. Sixty percent (n = 12) of female patients had
IUD. The patients had been wearing IUD for an average of
7 years, and 15% had been wearing an IUD for 3 years or
less. Confirmation of the diagnosis of actinomycosis was
done by histology in all cases. Microscopically, each of the
specimens showed chronic inflammatory reactions with
sulfur granules (Figs. 1 and 2). None of the patients under-
went percutaneous biopsy. There were no cancer cells found
in all patients. The average time to definitive diagnosis was
10.6 days (range, 4 - 19 days).
After a median follow up of 37.5 months (range, 6.6 -
23.1 months), recurrence was not seen in any patients. The
antibiotic of choice was IV penicillin, however, one patient
was given ciprofloxacin due to penicillin allergy. The
duration of treatment was 3 months in twelve patients, 6
months in five patients, 4 months in two patients and 1
month in two patients who refused to continue. 
Actinomycosis was first diagnosed in a live patient by
Ponfick in 1879.
11 It is a chronic suppurative disease caused
by an anaerobic, filamentous Gram positive bacteria.
12
Actinomycosis Israelii is a constant part of the microflora in
the human oral cavity, gastrointestinal and genital tracks.
12,13
The organism is unable to cross normal mucosal barrier,
therefore, opportunistic infections can occur only in context
of underlying local disease such as trauma, surgery, or a
foreign body which is significant enough to penetrate this
barrier. Once the organisms have penetrated the mucosa,
spread by continuity seems to be the primary method of
intrabdominal propagation. Lymphatic and hematogenous
spread is uncommon,
14,15 although there is a hematogenous
and lymphatic spread with nodal involvement reported.
16
Clinically, the disease follows an indolent course and the
initial presentation usually includes lower abdominal pain
and fever with or without a palpable mass as was seen in
our series. Since symptoms and signs are not specific, the
diagnosis is often delayed and only 10% of cases are diag-
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DISCUSSION
Fig. 1. 10.3 ×9.3 cm ovoid mass on the serosal surface of the cecum and
ascending colon with ulceration. The cut surface demonstrates typical light gray
color with necrosis.
Fig. 2. (A) A actinomycotic abscesses containing sulfur granules with radiating
filaments (H & E, ×100). (B) A magnified view of the characteristic sulfur granule
(H & E, ×200).
A
B
Table 3. Pre-Existing Diagnosis before Intrabdominal Acti-
nomycosis
Pre-existing diagnosis No. of patients (n = 22), %
Diverticulitis 2 (9.0)
PID 2 (9.0)
Pelvic mass 5 (22.8)
Tubovarian abscess* 5 (22.8)
Appendicitis 3 (13.6)
Lymphoma 3 (13.6) 
Endometriosis 1 (4.5)
Pelvic abscess 1 (4.5)
*One patient with combined sigmoid colon fistula. PID, pelvic inflammatory 
disease.nosed preoperatively.
16 In our series, only one patient (4.5%)
was diagnosed before surgery.
Intrabdominal actinomycosis can appear as an abdo-
minal mass of ambiguous benignity and can mimic a
malignant tumor. For example, actinomycosis of the colon
or the greater omentum is a rare differential diagnosis of
colonic carcinoma or peritoneal tumor.
17-19 The pathogenesis
of abdominal actinomycosis is not yet well understood.
There are two possibilities suggested that can affect
intrabdominal organs: through blood-borne infection or by
swallowing.
20 Actinomyces can normally inhabit colon,
predominating in areas of stagnation i.e. the cecum and
appendix. Actinomyces requires injury to the normal
mucosa to penetrate and cause disease. Predisposing
factors may include appendicitis and diverticulitis, gast-
rointestinal perforations, previous surgery, foreign bodies,
or neoplasia.
21 Thus, intrabdominal actinomycosis should
be included in differential along with other inflammatory
diseases such as ulcerative colitis, Crohn’s disease, tuber-
culosis, diverticulitis and pelvic inflammatory disease.
Pelvic actinomycosis has recently become more preva-
lent and is associated almost exclusively with women who
use IUDs.
16 Orogentital tract is thought to be an important
mode of acquiring this type of infection in lower genital
tract.
22 In the uterine cavity, the microorganisms are appa-
rently confined to the superficial layers of the mucosa, a
fact perhaps related to its cyclic shedding. The most likely
route of spread with subsequent development of pelvic
abscess appears to be through patent fallopian tubes. The
use of IUD may increase the risk of infection through
injury to the normal uterine mucosa.
13,23 Pelvic actinomy-
cosis associated with the use of IUDs can mimick pelvic
malignancy.
24 For such reason, it is often surgically excised.
However, if a diagnosis can properly be made preopera-
tively, antibiotic treatment and removal of IUD may lead
to complete remission, avoiding unnecessary surgery. In
our series, none of the patients with IUDs was diagnosed
of actinomycosis preoperatively. Fiorino
25 reported 92
patients with actinomycotic abscess in 63 case reports. In
this study, the average duration of IUD implantation was 8
years, and only 16% had been using an IUD for less than 3
years. Likewise, the average duration of IUD was 7 years
and only 15% of those patients had IUD for less than 3
years in our study. Although IUD is strongly correlated
with intrabdominal actinomycosis, a definite duration of
IUD implantation and the risk of developing actinomy-
cosis infection has not yet been established. 
The modern principle of therapy for actinomycosis
began with Peabody and Seabury in 1960,
26 who recom-
mended abscess drainage in combination with high dose
antibiotics. Smith et al.
27 reported that ciprofloxacin and
tetracyclines showed poor performance in antimicrobial
susceptibility testing of actinomyces species. Actinomyces
species appear to be susceptible to a wide range of beta-
lactam agents and, when combined with beta-lactamase
inhibitors, they should be regarded as agents of first
choice.
27 
Uncomplicated actinomycosis can be medically treated
by antibiotics, although there are differing opinions in the
literature about dosage and duration of antibiotic treat-
ment.
28,29 A prolonged treatment course is required because
of the poor penetration of antibiotics into the fibrotic tissues.
Thus, when there are more avascular spaces present due to
severe tissue reactions, medical therapy may be less effec-
tive, resulting in longer duration of antibiotic treatment,
regardless of the site of actinomycosis. Interestingly, two
patients in our series (9.0%) who were treated with iv anti-
biotics less than 4 weeks did not recur during the last 34
months of follow-up. Hence, the clinical impact of surgical
resection followed by short-term antibiotics merits for
further study. 
Even though intrabdominal actinomycosis is very rare in
its frequency, it should be included in a list of differential
diagnosis, especially in any women with a history of IUD
use who presents with abdominal pain or a pelvic mass. If
actinomycosis is suspected preoperatively, appropriate
handling of cultures will increase the diagnostic yield
which may spare the patient from an extensive surgery.
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